Content » Vol 83, Issue 4

Clinical Report

A Three-Year Randomized Trial in Patients with Dysplastic Naevi Treated with Oral Beta-carotene

Christiane Bayerl, Beate Schwarz, Ernst G. Jung
DOI: 10.1080/00015550310016535


Ultraviolet irradiation provokes the development of new melanocytic naevi, or changes in existing naevi, leading to repeated surgery of atypical naevi and becoming a continual burden for individuals with many of these lesions. To determine the influence of long-term medication with the radical scavenger ?-carotene on newly developing atypical naevi, a single-centre, randomized, placebo-controlled study, prospective over 3 years, was started double-blind in 62 patients with numerous clinically atypical naevi. Beta-carotene (25 mg) was given twice daily for 36 months in the treatment group (n =30) and saccharose capsules as placebo in the control group (n =32). The total number of newly developed naevi in the ?-carotene group (n =18) was 68 versus 88 in the placebo group (n =21) (not significant). Of 12 different locations on the human body evaluated separately, only in two, the lower arm (p =0.03) and the feet (p =0.03), was there a difference for the ?-carotene group in the quantification of naevi. Overall, it is concluded that ?-carotene does not reduce the development of new naevi in patients with numerous atypical naevi.


Supplementary content


Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.